AngioWaveNet vs Rapid RV/LV
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your cardiac catheterization lab requires enhanced, real-time vessel visualization during fluoroscopic angiograms to improve procedural guidance and decision-making. This tool is ideal for interventional procedures where clear and detailed imaging of blood vessels and anatomical structures is paramount, integrating seamlessly with your existing Cath lab workflow.
View AngioWaveNet →Choose Rapid RV/LV if…
Choose Rapid RV/LV if your radiology or cardiology department needs a rapid, automated assessment of pulmonary embolism severity from CTPA scans. This AI tool is best suited for quickly obtaining objective right and left ventricle ratio measurements to aid in timely diagnosis, risk stratification, and patient management for suspected PE cases.
View Rapid RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | Rapid RV/LV |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Contact vendor for pricing information. |
| Deployment | Cloud-based or on-premise/servers | On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AngioWaveNetAngioWaveNet emphasizes seamless integration with existing Cath lab workflows and vendor-agnostic compatibility, functioning as a DICOM endpoint. This suggests a lower barrier to adoption and easier integration into diverse hospital environments without requiring significant changes to current practices.
Clinical Value
Rapid RV/LVRapid RV/LV provides rapid, automated, and objective measurements of RV/LV ratios from CTPA scans, directly addressing pulmonary embolism severity assessment. Its ability to reduce inter-rater variability offers a clear, quantifiable improvement in diagnostic consistency and potentially faster, more accurate treatment decisions.
Pricing & Value
AngioWaveNetAngioWaveNet offers transparent pricing models, including annual software licensing or subscription-based access tailored to hospital needs, with custom packages available. In contrast, Rapid RV/LV requires contacting the vendor for pricing, which offers less upfront transparency.
Enterprise Readiness
TieBoth tools are FDA-cleared and HIPAA compliant, indicating readiness for healthcare environments. Both offer flexible deployment options (cloud/on-premise/hybrid) and integrate with hospital systems, making them suitable for enterprise adoption.
Innovation
Rapid RV/LVRapid RV/LV's innovation lies in automating a critical, time-sensitive measurement (RV/LV ratio) for pulmonary embolism severity, delivering rapid results and reducing inter-rater variability. This provides a distinct advancement in objective, rapid decision support compared to AngioWaveNet's image enhancement.
Support & Docs
Rapid RV/LVRapidAI, the company behind Rapid RV/LV, appears to have a more established and visible support infrastructure with dedicated sections for customer support, training, and resources on its website. Angiowave Imaging (Tool A) does not prominently feature a dedicated support portal or extensive documentation online.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | Rapid RV/LV |
|---|---|---|
| Name | AngioWaveNet | Rapid RV/LV |
| Company | Angiowave Imaging | RapidAI (formerly iSchemaView) |
| Description | FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows. | FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. |
| Primary Imaging Modality | Fluoroscopic angiograms | CTPA scans |
| Key Functionality | AI-powered Spatiotemporal Enhancement Processing (STEPu2122) for improved vessel visualization | Automated measurement of right and left ventricle diameters and RV/LV ratio for pulmonary embolism severity assessment |
| Specialties | Cardiology, Interventional Radiology, Vascular Surgery | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and Rapid RV/LV.